These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31514320)

  • 21. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.
    Kudolo GB; Bressler P; DeFronzo RA
    J Lipid Mediat Cell Signal; 1997 Nov; 17(2):97-113. PubMed ID: 9459136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects.
    Meshkani R; Zargari M; Larijani B
    Acta Diabetol; 2011 Mar; 48(1):79-88. PubMed ID: 21046418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose.
    Piché ME; Arcand-Bossé JF; Després JP; Pérusse L; Lemieux S; Weisnagel SJ
    Diabetes Care; 2004 Oct; 27(10):2470-7. PubMed ID: 15451918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretogranin III as a novel target for the therapy of choroidal neovascularization.
    LeBlanc ME; Wang W; Ji Y; Tian H; Liu D; Zhang X; Li W
    Exp Eye Res; 2019 Apr; 181():120-126. PubMed ID: 30633921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
    Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
    Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of metabolic syndrome and related clinical variables in determining CEA levels.
    Esteghamati A; Zandieh A; Saadipoor A; Hafezi-Nejad N; Noshad S; Esteghamati A; Seyedahmadinejad S; Nakhjavani M
    Adv Clin Exp Med; 2014; 23(6):907-12. PubMed ID: 25618116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
    Li JY; Wu GM; Hou Z; Cao YM
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.
    Chen YH; Lee YC; Tsao YC; Lu MC; Chuang HH; Yeh WC; Tzeng IS; Chen JY
    BMJ Open; 2018 May; 8(5):e016554. PubMed ID: 29724734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.
    Filippatos TD; Derdemezis CS; Kiortsis DN; Tselepis AD; Elisaf MS
    J Endocrinol Invest; 2007 Apr; 30(4):323-6. PubMed ID: 17556870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between osteocalcin and metabolic syndrome in postmenopausal women.
    Lee SW; Jo HH; Kim MR; Kim JH; You YO
    Arch Gynecol Obstet; 2015 Sep; 292(3):673-81. PubMed ID: 25716667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classical cardiovascular risk factors according to fasting plasma glucose levels.
    Martinez-Hervas S; Romero P; Hevilla EB; Real JT; Priego A; Martin-Moreno JM; Carmena R; Ascaso JF
    Eur J Intern Med; 2008 May; 19(3):209-13. PubMed ID: 18395166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.
    Park SE; Rhee EJ; Lee WY; Kim WJ; Yoo SH; Bae JC; Choi ES; Park CY; Oh KW; Park SW; Kim SW
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):525-32. PubMed ID: 21186114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous Adipose Tissue Type II Deiodinase Gene Expression Reduced in Obese Individuals with Metabolic Syndrome.
    Akarsu E; Korkmaz H; Oguzkan Balci S; Borazan E; Korkmaz S; Tarakcioglu M
    Exp Clin Endocrinol Diabetes; 2016 Jan; 124(1):11-5. PubMed ID: 26588490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-Peptide Is a Sensitive Indicator for the Diagnosis of Metabolic Syndrome in Subjects from Central Mexico.
    Gonzalez-Mejia ME; Porchia LM; Torres-Rasgado E; Ruiz-Vivanco G; Pulido-Pérez P; Báez-Duarte BG; Pérez-Fuentes R
    Metab Syndr Relat Disord; 2016 May; 14(4):210-6. PubMed ID: 26863426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome.
    Siu PM; Yuen QS
    Diabetol Metab Syndr; 2014; 6(1):119. PubMed ID: 25400701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome.
    Zhang H; Fan Q; Xie H; Lu L; Tao R; Wang F; Xi R; Hu J; Chen Q; Shen W; Zhang R; Yan X
    Front Endocrinol (Lausanne); 2017; 8():360. PubMed ID: 29312150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SHBG levels correlate with insulin resistance in postmenopausal women.
    Akin F; Bastemir M; Alkiş E; Kaptanoglu B
    Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.